Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori eradication for unexplained iron deficiency after negative endoscopy
ACTRN12607000287437Phase 4Not yet recruiting
- Sponsor
- St. Vincent's Health Australia
- Start
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clarithromycin + esomeprazole and ferrous sulfate in iron deficiency anemia (IDA) and Helicobacter pylori infection (3 arms), sponsored by St. Vincent's Health Australia. Primary endpoint: Persistent or recurrent iron deficiency over 8 months of follow-up. Planned start Jul 2007; status: not yet recruiting.
02
Drugs
amoxicillin + clarithromycin + esomeprazoleferrous sulfate
03
Conditions
iron deficiency anemia (IDA)Helicobacter pylori infection
Beyond the preview
Go deeper on ACTRN12607000287437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000287437.